Related Experiment Video
Updated: Nov 7, 2025
MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent
Published on: September 3, 2013
Prostate-specific Antigen Screening Using the Traditional Cutoff of 3 ng/ml: Pro
1Department of Surgery, Royal Melbourne Hospital and Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, Australia; EJ Whitten Prostate Cancer Research Centre at Epworth, Melbourne, Australia.
Abstract:
Prostate-specific antigen remains the primary tumour marker in oncology. In the screening setting, if one avoids an age-adjusted cutoff, then logically 3.0 ng/ml is the level that should lead to interrogation, including repeat measurement and imaging.
More Related Videos
06:08A Cognitive Fusion-guided Prostate Biopsy Using Multiparametric Magnetic Resonance Imaging and Transrectal Ultrasound
Published on: March 21, 2025
13:19Microarray-based Identification of Individual HERV Loci Expression: Application to Biomarker Discovery in Prostate Cancer
Published on: November 2, 2013